On the public citation graph

Cellular Fitness Phenotypes of Cancer Target Genes from Oncobiology to Cancer Therapeutics

https://doi.org/10.1101/840975
0 signed · 75 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/jama.2016.19425openalex-snapshot
Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases
inferredcites →https://doi.org/10.1001/jamaoncol.2016.6316openalex-snapshot
Continued Treatment Effect of Zoledronic Acid Dosing Every 12 vs 4 Weeks in Women With Breast Cancer Metastatic to Bone
inferredcites →https://doi.org/10.1002/14651858.cd003474.pub4openalex-snapshot
Bisphosphonates and other bone agents for breast cancer
inferredcites →https://doi.org/10.1007/s10549-019-05267-zopenalex-snapshot
Impact of long-term lipid-lowering therapy on clinical outcomes in breast cancer
inferredcites →https://doi.org/10.1007/s40257-018-0384-3openalex-snapshot
Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
inferredcites →https://doi.org/10.1016/j.critrevonc.2009.11.005openalex-snapshot
First-line single-agent cetuximab in elderly patients with metastatic colorectal cancer. A phase II clinical and molecular study of the Spanish group for digestive tumor therapy (TTD)
inferredcites →https://doi.org/10.1016/j.ctrv.2011.09.003openalex-snapshot
Direct and indirect anticancer activity of bisphosphonates: A brief review of published literature
inferredcites →https://doi.org/10.1016/j.ejca.2011.06.025openalex-snapshot
Melanoma antigen family A identified by the bimodality index defines a subset of triple negative breast cancers as candidates for immune response augmentation
inferredcites →https://doi.org/10.1016/j.gdata.2014.09.014openalex-snapshot
Control of dataset bias in combined Affymetrix cohorts of triple negative breast cancer
inferredcites →https://doi.org/10.1016/j.jtho.2016.10.021openalex-snapshot
Clinical Impact of Hybrid Capture–Based Next-Generation Sequencing on Changes in Treatment Decisions in Lung Cancer
inferredcites →https://doi.org/10.1016/j.yrtph.2014.06.012openalex-snapshot
Functional differentiation of cytotoxic cancer drugs and targeted cancer therapeutics
inferredcites →https://doi.org/10.1016/s0140-6736(10)61121-xopenalex-snapshot
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
inferredcites →https://doi.org/10.1016/s0140-6736(10)62051-xopenalex-snapshot
First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial
inferredcites →https://doi.org/10.1016/s1470-2045(17)30603-4openalex-snapshot
Effect of MAF amplification on treatment outcomes with adjuvant zoledronic acid in early breast cancer: a secondary analysis of the international, open-label, randomised, controlled, phase 3 AZURE (BIG 01/04) trial
inferredcites →https://doi.org/10.1016/s1470-2045(17)30695-2openalex-snapshot
Adjuvant zoledronic acid to treat breast cancer: not for all
inferredcites →https://doi.org/10.1016/s1476-5586(04)80047-2openalex-snapshot
ONCOMINE: A Cancer Microarray Database and Integrated Data-Mining Platform
inferredcites →https://doi.org/10.1016/s2213-2600(18)30264-9openalex-snapshot
Detection of EGFR mutations in plasma circulating tumour DNA as a selection criterion for first-line gefitinib treatment in patients with advanced lung adenocarcinoma (BENEFIT): a phase 2, single-arm, multicentre clinical trial
inferredcites →https://doi.org/10.1021/cb500886nopenalex-snapshot
Unexpected Off-Targets and Paradoxical Pathway Activation by Kinase Inhibitors
inferredcites →https://doi.org/10.1038/nature03095openalex-snapshot
Targeted cancer therapy
inferredcites →https://doi.org/10.1038/nature18003openalex-snapshot
Proteogenomics connects somatic mutations to signalling in breast cancer
inferredcites →https://doi.org/10.1038/ncomms11479openalex-snapshot
The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes
inferredcites →https://doi.org/10.1038/nrc.2017.32openalex-snapshot
Common pitfalls in preclinical cancer target validation
inferredcites →https://doi.org/10.1038/nrclinonc.2010.134openalex-snapshot
Future directions of bone-targeted therapy for metastatic breast cancer
inferredcites →https://doi.org/10.1038/nrd.2016.230openalex-snapshot
A comprehensive map of molecular drug targets
inferredcites →https://doi.org/10.1038/s41388-019-0791-9openalex-snapshot
FDPS cooperates with PTEN loss to promote prostate cancer progression through modulation of small GTPases/AKT axis
inferredcites →https://doi.org/10.1038/s41586-019-1103-9openalex-snapshot
Prioritization of cancer therapeutic targets using CRISPR–Cas9 screens
inferredcites →https://doi.org/10.1038/sigtrans.2015.1openalex-snapshot
Human IgG1 antibodies suppress angiogenesis in a target-independent manner
inferredcites →https://doi.org/10.1053/j.gastro.2013.11.046openalex-snapshot
Statin Use Is Associated With Reduced Risk of Histologic Subtypes of Esophageal Cancer: A Nested Case-Control Analysis
inferredcites →https://doi.org/10.1056/nejmoa1413513openalex-snapshot
Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer
inferredcites →https://doi.org/10.1093/annonc/mdn429openalex-snapshot
Adjuvant oral clodronate improves the overall survival of primary breast cancer patients with micrometastases to the bone marrow—a long-term follow-up
inferredcites →https://doi.org/10.1093/database/bav051openalex-snapshot
HCSD: the human cancer secretome database
inferredcites →https://doi.org/10.1093/jnci/djv256openalex-snapshot
Enhanced MAF Oncogene Expression and Breast Cancer Bone Metastasis
inferredcites →https://doi.org/10.1093/nar/gkj067openalex-snapshot
DrugBank: a comprehensive resource for in silico drug discovery and exploration
inferredcites →https://doi.org/10.1093/nar/gkm958openalex-snapshot
DrugBank: a knowledgebase for drugs, drug actions and drug targets
inferredcites →https://doi.org/10.1093/nar/gkq1126openalex-snapshot
DrugBank 3.0: a comprehensive resource for 'Omics' research on drugs
inferredcites →https://doi.org/10.1093/nar/gkt1068openalex-snapshot
DrugBank 4.0: shedding new light on drug metabolism
inferredcites →https://doi.org/10.1093/nar/gkx1037openalex-snapshot
DrugBank 5.0: a major update to the DrugBank database for 2018
inferredcites →https://doi.org/10.1093/nar/gky1020openalex-snapshot
Haemopedia RNA-seq: a database of gene expression during haematopoiesis in mice and humans
inferredcites →https://doi.org/10.1093/nar/gky1064openalex-snapshot
Stemformatics: visualize and download curated stem cell data
inferredcites →https://doi.org/10.1093/nar/gky872openalex-snapshot
Cell Model Passports—a hub for clinical, genetic and functional datasets of preclinical cancer models
inferredcites →https://doi.org/10.1097/md.0000000000016480openalex-snapshot
The association between statin use and survival of esophageal cancer patients
inferredcites →https://doi.org/10.1101/326470openalex-snapshot
The UCSC Xena platform for public and private cancer genomics data visualization and interpretation
inferredcites →https://doi.org/10.1111/j.1472-8206.1990.tb00079.xopenalex-snapshot
Specificity of the phase I trial for cytotoxic drugs in oncology
inferredcites →https://doi.org/10.1126/science.1260419openalex-snapshot
Tissue-based map of the human proteome
inferredcites →https://doi.org/10.1126/scisignal.2004088openalex-snapshot
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
inferredcites →https://doi.org/10.1126/scitranslmed.aan0026openalex-snapshot
Neoadjuvant chemotherapy induces breast cancer metastasis through a TMEM-mediated mechanism
inferredcites →https://doi.org/10.1126/scitranslmed.aaw8412openalex-snapshot
Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials
inferredcites →https://doi.org/10.1158/0008-5472.can-14-0673openalex-snapshot
Phosphatase PTP4A3 Promotes Triple-Negative Breast Cancer Growth and Predicts Poor Patient Survival
inferredcites →https://doi.org/10.1158/0008-5472.can-19-0989openalex-snapshot
A Tribute to John Mendelsohn: A Pioneer in Targeted Cancer Therapy
inferredcites →https://doi.org/10.1158/1078-0432.ccr-14-0432openalex-snapshot
Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer
inferredcites →https://doi.org/10.1158/2159-8290.cd-12-0095openalex-snapshot
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
inferredcites →https://doi.org/10.1158/2159-8290.cd-15-0012openalex-snapshot
Real-Time Imaging Reveals Local, Transient Vascular Permeability, and Tumor Cell Intravasation Stimulated by TIE2hi Macrophage–Derived VEGFA
inferredcites →https://doi.org/10.1177/1758835919853971openalex-snapshot
Neoadjuvant zoledronic acid for HER2-positive breast cancer: the Zo-NAnTax trial
inferredcites →https://doi.org/10.1186/bcr3035openalex-snapshot
A clinically relevant gene signature in triple negative and basal-like breast cancer
inferredcites →https://doi.org/10.1186/s12885-018-5263-zopenalex-snapshot
Statin use and breast cancer survival – a Swedish nationwide study
inferredcites →https://doi.org/10.1186/s12911-019-0743-xopenalex-snapshot
Treatment recommendations to cancer patients in the context of FDA guidance for next generation sequencing
inferredcites →https://doi.org/10.1186/s13058-015-0550-yopenalex-snapshot
Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response
inferredcites →https://doi.org/10.1186/s13058-016-0690-8openalex-snapshot
Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer
inferredcites →https://doi.org/10.1186/s13058-019-1148-6openalex-snapshot
Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
inferredcites →https://doi.org/10.1186/s13063-018-2851-9openalex-snapshot
Zoledronic acid in the management of mesothelioma - a feasibility study (Zol-A Trial): study protocol for a randomised controlled trial
inferredcites →https://doi.org/10.1200/cci.17.00010openalex-snapshot
Epidemiologic Analysis Along the Mevalonate Pathway Reveals Improved Cancer Survival in Patients Who Receive Statins Alone and in Combination With Bisphosphonates
inferredcites →https://doi.org/10.1200/jco.20.3.719openalex-snapshot
Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer
inferredcites →https://doi.org/10.1200/jco.2012.46.8934openalex-snapshot
Genomics-Driven Oncology: Framework for an Emerging Paradigm
inferredcites →https://doi.org/10.1210/me.2009-0276openalex-snapshot
Minireview: The SRC Family of Coactivators: An Entree to Understanding a Subset of Polygenic Diseases?
inferredcites →https://doi.org/10.1248/bpb.b15-00746openalex-snapshot
Synergistic Antiproliferative Effects of Zoledronic Acid and Fluvastatin on Human Pancreatic Cancer Cell Lines: An in Vitro Study
inferredcites →https://doi.org/10.1371/journal.pone.0028403openalex-snapshot
Homogeneous Datasets of Triple Negative Breast Cancers Enable the Identification of Novel Prognostic and Predictive Signatures
inferredcites →https://doi.org/10.1371/journal.pone.0074250openalex-snapshot
SurvExpress: An Online Biomarker Validation Tool and Database for Cancer Gene Expression Data Using Survival Analysis
inferredcites →https://doi.org/10.1586/era.11.71openalex-snapshot
Zoledronic acid: multiplicity of use across the cancer continuum
inferredcites →https://doi.org/10.1634/theoncologist.12-12-1443openalex-snapshot
Review: Side Effects of Approved Molecular Targeted Therapies in Solid Cancers
inferredcites →https://doi.org/10.1634/theoncologist.2017-0396openalex-snapshot
Ki67 Changes Identify Worse Outcomes in Residual Breast Cancer Tumors After Neoadjuvant Chemotherapy
inferredcites →https://doi.org/10.18632/oncotarget.10746openalex-snapshot
High expression of cholesterol biosynthesis genes is associated with resistance to statin treatment and inferior survival in breast cancer
inferredcites →https://doi.org/10.18632/oncotarget.4817openalex-snapshot
Genome-wide RNAi analysis reveals that simultaneous inhibition of specific mevalonate pathway genes potentiates tumor cell death
inferredcites →https://doi.org/10.2174/1871520613666131129105035openalex-snapshot
Statins and Cancer
inferredcites →https://doi.org/10.3390/ijms19113333openalex-snapshot
Chemotherapy-Exacerbated Breast Cancer Metastasis: A Paradox Explainable by Dysregulated Adaptive-Response
inferredcites →https://doi.org/10.4081/oncol.2018.346openalex-snapshot
The role of pemetrexed in recurrent epithelial ovarian cancer: A scoping review
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.